A combination of pertuzimab and Enhertu can slow disease progression and improve survival in people with HER2-positive ...

AstraZeneca has warned that countries must buy more of its cutting-edge medicines or jobs and investment will shift abroad.

AstraZeneca may face a fine of up to $8 million in China over suspected unpaid taxes related to the import of its breast ...

AstraZeneca said today it may face a fine of up to $8m over suspected unpaid import taxes in China as the drugmaker works to ...

AstraZeneca expects only limited impact from potential U.S. tariffs on pharmaceutical imports, the drugmaker said on Tuesday, ...

AstraZeneca posts Q1 revenue of $13.59 billion and a strong EPADS beat; oncology leads growth as China's tax probe and halts ...

AstraZeneca (NASDAQ:AZN) on Tuesday said it may face a fine of up to $8 million over suspected unpaid import taxes in China.

Despite AstraZeneca’s falling share price today, this writer believes the London-listed pharmaceutical giant could be worth a ...

Roche has claimed a breakthrough designation from the FDA for a cancer test that combines an antibody assay with artificial ...

Expectations for the full year Core tax rate are unchanged at 18-22% Core EPS increased 21% to $2.49 Five positive Phase III readouts and 13 approvals in major regions since the prior results Pascal ...

AstraZeneca posted increased core earnings per share and sales for the first quarter but warned of mounting legal challenges in China.